threonine and atorvastatin

threonine has been researched along with atorvastatin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Graeff, CF; Herculano, RD; Nagassaki, S; Tanus-Santos, JE	1
Arzeno, J; Bellovin, DI; Cao, Z; Fan-Minogue, H; Felsher, DW; Gambhir, SS; Yang, Q; Yevtodiyenko, A	1

Other Studies

2 other study(ies) available for threonine and atorvastatin

Article	Year
eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. European journal of clinical pharmacology, 2009, Volume: 65, Issue:4 Topics: Adult; Atorvastatin; Cholesterol; Cysteine; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Genotype; Hemorheology; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Fluidity; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Pyrroles; Thiobarbiturates; Threonine; Young Adult	2009
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer research, 2011, Mar-15, Volume: 71, Issue:6 Topics: Animals; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Hep G2 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Kaplan-Meier Estimate; Liver Neoplasms; Mice; Mice, SCID; Mice, Transgenic; Mutation; Phosphorylation; Proto-Oncogene Proteins c-myc; Pyrroles; rac GTP-Binding Proteins; Serine; Threonine; Tumor Burden; Xenograft Model Antitumor Assays	2011

Article

Year

eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.

European journal of clinical pharmacology, 2009, Volume: 65, Issue:4

Topics: Adult; Atorvastatin; Cholesterol; Cysteine; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Genotype; Hemorheology; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Fluidity; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Pyrroles; Thiobarbiturates; Threonine; Young Adult

2009

MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.

Cancer research, 2011, Mar-15, Volume: 71, Issue:6

Topics: Animals; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Hep G2 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Kaplan-Meier Estimate; Liver Neoplasms; Mice; Mice, SCID; Mice, Transgenic; Mutation; Phosphorylation; Proto-Oncogene Proteins c-myc; Pyrroles; rac GTP-Binding Proteins; Serine; Threonine; Tumor Burden; Xenograft Model Antitumor Assays

2011